Predictor | B | SE | Wald | Significance | OR | 95% CI for OR | |
---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
Males | |||||||
Age | 1.068 | 0.10 | 108.65 | <0.001 | 2.91 | 2.38 | 3.56 |
UA | −0.003 | 0.00 | 7.01 | 0.008 | 1.00 | 0.99 | 1.00 |
TC | 1.28 | 0.20 | 43.33 | <0.001 | 3.61 | 2.46 | 5.29 |
lnTG | −0.37 | 0.20 | 3.23 | 0.072 | 0.69 | 0.47 | 1.03 |
apoA | −5.42 | 0.52 | 108.39 | <0.001 | 0.00 | 0.00 | 0.01 |
apoB | −6.66 | 0.77 | 75.82 | <0.001 | 0.00 | 0.00 | 0.01 |
lnHCY | 2.66 | 0.33 | 66.53 | <0.001 | 14.22 | 7.51 | 26.91 |
lnGGT | 1.07 | 0.18 | 35.17 | <0.001 | 2.90 | 2.04 | 4.13 |
Constant | −6.91 | 1.28 | 29.24 | <0.001 | 0.00 | – | – |
Females | |||||||
Age | 1.728 | 0.24 | 51.22 | <0.001 | 5.63 | 3.51 | 9.03 |
TC | 1.39 | 0.31 | 20.32 | <0.001 | 4.01 | 2.19 | 7.33 |
apoA | −7.38 | 1.24 | 35.35 | <0.001 | 0.00 | 0.00 | 0.01 |
apoB | −1.77 | 0.78 | 5.15 | 0.023 | 0.17 | 0.04 | 0.79 |
lnLp(a) | −0.39 | 0.22 | 3.15 | 0.076 | 0.68 | 0.44 | 1.04 |
lnHCY | 2.98 | 0.50 | 36.37 | <0.001 | 19.76 | 7.49 | 52.10 |
lnTBil | −1.75 | 0.58 | 9.04 | 0.003 | 0.17 | 0.06 | 0.55 |
lnGGT | 0.89 | 0.29 | 9.53 | 0.002 | 2.43 | 1.38 | 4.26 |
HDL-C vs LDL-C | 4.74 | 1.60 | 8.82 | 0.003 | 114.20 | 5.01 | 2603.02 |
Constant | −9.22 | 2.61 | 12.51 | <0.001 | 0.00 | – | – |
B indicates that the unstandardised partial regression coefficient for 1 unit increased.
apoA, apolipoprotein A; apoB, apolipoprotein B; B, coefficient; CHD, coronary heart disease; GGT, γ-glutamyl transpeptidase; HCY, homocysteine; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ln, logarithm transformed; Lp(a), lipoprotein(a); TBil, total bilirubin; TC, total cholesterol; UA, uric acid.
ORs for continuous variables=OR for an increase of 1 unit except age, for which OR is for an increase of 10 units.